A new artificial intelligence (AI) tool that can detect heart disease in record speed, helping to improve care for heart patients, is being rolled out at UCLH.
People without jobs or with less secure housing have poorer outcomes when treated for depression with talking therapy or antidepressants, compared to more socially advantaged peers, according to UCL led research.
A single DNA test has been developed that can screen a patient’s genome for over 50 genetic neurological and neuromuscular diseases such as Huntington’s disease, muscular dystrophies and fragile X syndrome.
Two UCL and UCLH studies will look at whether analysis of advanced MRI scans can predict onset of multiple sclerosis and indicate which MS patients are at risk of developing irreversible disability.
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
A collaboration between UCLH, UCL and industry to cut use of anaesthetic gases has been awarded £99,703 by SBRI Healthcare – an NHS funded programme to support an historic drive to deliver a net zero NHS.
It is safe and effective to vaccinate people with inflammatory or autoimmune rheumatic and musculoskeletal diseases such as arthritis and lupus, a study led by UCL has found.
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death.
